Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Berk

Showing results (331-340 of 398) with videos related to

Pageof 40
Sort By:
Journal of Affective Disorders|December 1, 2009
A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorderS Dodd, J Kulkarni, L Berk, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 12, 2021
Tissue biopsy for the diagnosis of amyloidosis: experience from some centresMerrill D Benson, John L Berk, Angela Dispenzieri, et al.
Journal of Affective Disorders|February 28, 2007
History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorderM Berk, S Dodd, P Callaly, et al.
Journal of Cardiac Failure|December 6, 2019
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac AmyloidosisGraham Lohrmann, Alexandra Pipilas, Roberta Mussinelli, et al.
Orphanet Journal of Rare Diseases|February 22, 2013
Guideline of transthyretin-related hereditary amyloidosis for cliniciansYukio Ando, Teresa Coelho, John L Berk, et al.
European Journal of Heart Failure|February 7, 2024
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathyPablo Garcia-Pavia, Martha Grogan, Parag Kale, et al.
Bone Marrow Transplantation|December 17, 2003
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trialV Sanchorawala, D G Wright, D C Seldin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2001
The care of HIV-infected adults in rural areas of the United StatesS E Cohn, M L Berk, S H Berry, et al.
The American Journal of Cardiology|August 26, 2022
Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate ImagingRabah Alreshq, Matthew Cozzolino, Brian Lilleness, et al.
Muscle & Nerve|November 18, 2024
Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health-Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin AmyloidosisFolke Folkvaljon, Morie Gertz, Julian D Gillmore, et al.
Pageof 40

Showing results (331-340 of 398) with videos related to

Sort By:
Pageof 40
Journal of Affective Disorders|December 1, 2009
A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorderS Dodd, J Kulkarni, L Berk, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 12, 2021
Tissue biopsy for the diagnosis of amyloidosis: experience from some centresMerrill D Benson, John L Berk, Angela Dispenzieri, et al.
Journal of Affective Disorders|February 28, 2007
History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorderM Berk, S Dodd, P Callaly, et al.
Journal of Cardiac Failure|December 6, 2019
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac AmyloidosisGraham Lohrmann, Alexandra Pipilas, Roberta Mussinelli, et al.
Orphanet Journal of Rare Diseases|February 22, 2013
Guideline of transthyretin-related hereditary amyloidosis for cliniciansYukio Ando, Teresa Coelho, John L Berk, et al.
European Journal of Heart Failure|February 7, 2024
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathyPablo Garcia-Pavia, Martha Grogan, Parag Kale, et al.
Bone Marrow Transplantation|December 17, 2003
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trialV Sanchorawala, D G Wright, D C Seldin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2001
The care of HIV-infected adults in rural areas of the United StatesS E Cohn, M L Berk, S H Berry, et al.
The American Journal of Cardiology|August 26, 2022
Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate ImagingRabah Alreshq, Matthew Cozzolino, Brian Lilleness, et al.
Muscle & Nerve|November 18, 2024
Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health-Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin AmyloidosisFolke Folkvaljon, Morie Gertz, Julian D Gillmore, et al.
Pageof 40